DNA

MKT CAP:$489M

Ginkgo Bioworks Holdings, Inc.

Market Cap

$489M

Healthcare·Biotechnology·🇺🇸 United States·NYSE

Healthcare·Biotechnology·🇺🇸·NYSE

Stock Price

$8.47-$0.22 (-2.59%)

Apr 22, 2026

Company Details

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and che...

CEO

Jason Kelly

IPO Date

Apr 19, 2021

Website

www.ginkgobioworks.com

Key Metrics TTM

Revenue

$170M

-25.1% YoY

Net Income

-$313M

EPS (Diluted)

-$5.66

Free Cash Flow

-$194M

Revenue / Share

$3.07

Gross Margin

81.5%

Operating Margin

-185.3%

Net Margin

-183.8%

FCF Margin

-114.0%

P/S

2.9x

P/E

—

Earnings Reports

Q1 2026

May 5, 2026

PENDING

FY 2025

Feb 26, 2026

$170M-25.1%EPS -$5.64

Q4 2025

Feb 26, 2026

$33M-23.8%EPS -$1.43

Q3 2025

Nov 6, 2025

$39M-56.4%EPS -$1.45

Q2 2025

Aug 7, 2025

$50M-11.7%EPS -$1.10

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$148M	$82M	-$1.7B
Q1 22	$168M	$83M	-$675M
Q2 22	$145M	$81M	-$648M
Q3 22	$66M	$42M	-$655M
Q1 23	$81M	$58M	-$216M
Q2 23	$81M	$62M	-$184M
Q3 23	$55M	$49M	-$286M
Q4 23	$35M	$28M	-$178M
Q1 24	$38M	$29M	-$178M
Q2 24	$56M	$42M	-$223M
Q3 24	$89M	$79M	-$55M
Q4 24	$44M	$34M	-$104M
Q1 25	$48M	$36M	-$89M
Q2 25	$50M	$35M	-$66M
Q3 25	$39M	$26M	-$90M
Q4 25	$33M	$42M	-$71M

Valuation

Quarter	P/S	P/E
Q4 21	44.2x	—
Q1 22	13.6x	—
Q2 22	8.4x	—
Q3 22	10.8x	—
Q1 23	5.3x	—
Q2 23	9.3x	—
Q3 23	11.9x	—
Q4 23	12.4x	—
Q1 24	11.0x	—
Q2 24	3.7x	—
Q3 24	1.9x	—
Q4 24	2.2x	—
Q1 25	1.3x	—
Q2 25	2.7x	—
Q3 25	4.1x	—
Q4 25	2.7x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	-$166M	-$171M
Q1 22	-$20M	-$23M
Q2 22	-$99M	-$109M
Q3 22	-$28M	-$42M
Q1 23	-$91M	-$110M
Q2 23	-$74M	-$87M
Q3 23	-$74M	-$78M
Q4 23	-$58M	-$61M
Q1 24	-$89M	-$96M
Q2 24	-$84M	-$111M
Q3 24	-$104M	-$119M
Q4 24	-$42M	-$56M
Q1 25	-$52M	-$59M
Q2 25	-$40M	-$40M
Q3 25	-$32M	-$32M
Q4 25	-$48M	-$63M

Capital Expenditures

Quarter	CapEx
Q4 21	$5M
Q1 22	$4M
Q2 22	$10M
Q3 22	$13M
Q1 23	$19M
Q2 23	$14M
Q3 23	$4M
Q4 23	$3M
Q1 24	$7M
Q2 24	$27M
Q3 24	$15M
Q4 24	$14M
Q1 25	$8M
Q2 25	$38.0K
Q3 25	$0
Q4 25	$15M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+1016.3%	+3742.0%
Q1 22	+281.9%	+733.7%
Q2 22	+231.4%	+665.0%
Q3 22	-14.4%	+591.7%
Q1 23	-45.7%	-83.8%
Q2 23	-52.2%	-68.6%
Q3 23	-61.7%	-56.9%
Q4 23	-47.7%	-70.5%
Q1 24	-53.0%	-27.2%
Q2 24	-30.2%	+5.5%
Q3 24	+60.6%	-57.8%
Q4 24	+26.2%	-30.7%
Q1 25	+27.3%	-36.4%
Q2 25	-11.7%	-58.8%
Q3 25	-56.4%	-10.7%
Q4 25	-23.8%	-29.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$0	0.0%
Q1 22	$0	0.0%
Q2 22	$0	0.0%
Q3 22	$0	0.0%
Q1 23	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$53M	94.8%
Q4 23	$0	0.0%
Q1 24	$41M	107.5%
Q2 24	$37M	66.1%
Q3 24	$0	0.0%
Q4 24	$21M	46.9%
Q1 25	$20M	42.3%
Q2 25	$22M	44.8%
Q3 25	$18M	45.9%
Q4 25	$21M	63.0%

OpEx Breakdown

Quarter	R&D	G&A
Q4 21	$985M	$782M
Q1 22	$324M	$435M
Q2 22	$290M	$438M
Q3 22	$261M	$435M
Q1 23	$163M	$111M
Q2 23	$144M	$102M
Q3 23	$157M	$82M
Q4 23	$117M	$89M
Q1 24	$136M	$70M
Q2 24	$134M	$66M
Q3 24	$77M	$52M
Q4 24	$76M	$57M
Q1 25	$71M	$49M
Q2 25	$53M	$43M
Q3 25	$69M	$45M
Q4 25	$50M	$46M

Revenue Segments

Quarter	Foundry Revenue	Product	Service
Q1 22	$21M	$14M	$133M
Q2 22	$44M	$4M	$96M
Q3 22	$25M	$5M	$37M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$1.5B	$0	$1.5B
Q2 22	$1.4B	$0	$1.4B
Q3 22	$1.3B	$0	$1.3B
Q4 22	$1.3B	$0	$1.3B
Q1 23	$1.2B	$0	$1.2B
Q2 23	$1.1B	$0	$1.1B
Q3 23	$1.0B	$0	$1.0B
Q4 23	$944M	$0	$944M
Q1 24	$844M	$0	$844M
Q2 24	$730M	$0	$730M
Q3 24	$616M	$0	$616M
Q4 24	$562M	$0	$562M
Q1 25	$312M	$205M	$517M
Q2 25	$204M	$270M	$474M
Q3 25	$111M	$351M	$462M
Q4 25	$167M	$255M	$423M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	38M	+15.7%	+19.0%
Q1 22	40M	+5.0%	+24.6%
Q2 22	41M	+0.8%	+25.4%
Q3 22	41M	+0.6%	+23.2%
Q1 23	48M	+17.5%	+25.1%
Q2 23	48M	+0.9%	+20.3%
Q3 23	49M	+0.9%	+20.4%
Q4 23	49M	+1.4%	+21.3%
Q1 24	50M	+1.1%	+4.3%
Q2 24	51M	+2.8%	+6.3%
Q3 24	52M	+1.7%	+7.1%
Q4 24	52M	-0.7%	+4.9%
Q1 25	54M	+4.5%	+8.5%
Q2 25	55M	+1.1%	+6.8%
Q3 25	56M	+1.4%	+6.5%
Q4 25	55M	-0.3%	+6.9%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	$231.7K	641
Q1 22	$262.7K	641
Q2 22	$225.6K	641
Q3 22	$103.6K	641
Q1 23	$62.5K	1K
Q2 23	$62.4K	1K
Q3 23	$42.9K	1K
Q4 23	$28.5K	1K
Q1 24	$31.2K	1K
Q2 24	$46.1K	1K
Q3 24	$73.1K	1K
Q4 24	$52.6K	834
Q1 25	$57.9K	834
Q2 25	$59.5K	834
Q3 25	$46.6K	834
Q4 25	$68.9K	485

Revenue / Employee